3rd Fluid & Imaging Biomarkers in Neuroscience Summit

This Event has Passed

Tuesday, October 07, 2025 - 8:00 AM
to Thursday, October 09, 2025 - 5:00 PM

Add to Calendar

10/07/2025 08:00 AM 10/09/2025 05:00 PM America/Anguilla 3rd Fluid & Imaging Biomarkers in Neuroscience Summit As the only industry-driven forum focused exclusively on biomarker discovery and validation for neurodegenerative and neuroinflammatory diseases, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit unites biotech, pharma and academic scientists to transform diagnosis and monitoring of Alzheimer’s, Parkinson’s, ALS, and MS. Join 80+ experts from Roche, Prothena, Eisai, Michael J. Fox Foundation and more to decode regulatory pathways, optimize IND timing, and harness breakthrough insights in p-tau217, alpha-synuclein, emerging omics platforms, and more. As the field rapidly shifts toward blood-based diagnostics, high-sensitivity assays, and regulatory clarity, this is your unparalle... Details & Tickets: https://www.upcomingevents.com/boston/events/revere-hotel-boston-common/3rd-fluid-imaging-biomarkers-in-neuroscience-summit-484766?ref=uceaddevent Revere Hotel Boston Common, 200 Stuart Street, Boston, MA, 02116

Neighborhoods

Bay Village (Boston)
Beacon Hill (Boston)
Chinatown (Boston)
Downtown Crossing (Boston)

View Event Website »

As the only industry-driven forum focused exclusively on biomarker discovery and validation for neurodegenerative and neuroinflammatory diseases, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit unites biotech, pharma and academic scientists to transform diagnosis and monitoring of Alzheimer’s, Parkinson’s, ALS, and MS. Join 80+ experts from Roche, Prothena, Eisai, Michael J. Fox Foundation and more to decode regulatory pathways, optimize IND timing, and harness breakthrough insights in p-tau217, alpha-synuclein, emerging omics platforms, and more. As the field rapidly shifts toward blood-based diagnostics, high-sensitivity assays, and regulatory clarity, this is your unparalleled opportunity to collaborate with CNS biomarker leaders to shape a new wave of omics-based discoveries, surrogate endpoint success stories, pre-symptomatic detection technologies, and more.

Event Links

Website: https://go.evvnt.com/3137146-0

Tickets: https://go.evvnt.com/3137146-2

Brochure: https://go.evvnt.com/3137146-3

View Less